A $100m (£68m) Dementia Discovery Fund was announced at the World’s Health Organisation’s First Ministerial Conference on Global Action Against Dementia last month to boost medical research into the disease.Pharmaceutical giants Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly and Pfizer have committed in principal to investing in the project, the Department of Health said. Alzheimer’s Research…
Membership Required
You must be a CM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
